Back to results
US 2019/0153408 A1Published application
Bifidobacterium longum
AssigneesThe Procter & Gamble Company, Alimentary Health Ltd.
InventorsJose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
Life of this patent
Estimating the term…
Abstract
A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
Claims19
A formulation comprising an ingestable carrier and an isolated strain of Bifidobacterium longum , excluding Bifidobacterium longum strains
- 35624 (NCIMB 41003)
- BL1207 (PTA-9608);
- AH121A (NCIMB 41675);
- AH1714 (NCIMB 41676);
- and
- AH1206 (NCIMB 41382)
- wherein the strain:
- a) expresses an exopolysaccharide containing 6-deoxy talose;
- and
- b) comprises nucleic acid sequence SEQ ID NO:
- 86 or nucleic acid sequences with at least 95% sequence homology thereto that codes for protein-tyrosine-phosphatase.
8 more elements
Dependencies are inferred from the claim text.